Correlation Between Emergent Biosolutions and Teva Pharma

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Teva Pharma Industries, you can compare the effects of market volatilities on Emergent Biosolutions and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Teva Pharma.

Diversification Opportunities for Emergent Biosolutions and Teva Pharma

0.62

Correlation Coefficient

Emergent Biosolutions  Teva Pharma

Poor diversification

The 3 months correlation between Emergent and Teva is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Teva Pharma go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Teva Pharma

Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Teva Pharma. In addition to that, Emergent Biosolutions is 1.57 times more volatile than Teva Pharma Industries. It trades about -0.23 of its total potential returns per unit of risk. Teva Pharma Industries is currently generating about -0.21 per unit of volatility. If you would invest  2,232  in Teva Pharma Industries on December 28, 2024 and sell it today you would lose (724.00) from holding Teva Pharma Industries or give up 32.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Teva Pharma Industries

Emergent Biosolutions

Risk-Adjusted Performance

Very Weak

Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Teva Pharma Industries

Risk-Adjusted Performance

Very Weak

Over the last 90 days Teva Pharma Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Emergent Biosolutions and Teva Pharma

The main advantage of trading using opposite Emergent Biosolutions and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.

The idea behind Emergent Biosolutions and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.